Department of Psychology, University of North Carolina, Chapel Hill, NC, USA.
Neuropsychopharmacology. 2010 May;35(6):1241-52. doi: 10.1038/npp.2009.209. Epub 2010 Feb 3.
Recent evidence suggests that corticotropin-releasing factor (CRF) receptor (CRFR) signaling is involved in modulating binge-like ethanol consumption in C57BL/6J mice. In this report, a series of experiments were performed to further characterize the role of CRFR signaling in binge-like ethanol consumption. The role of central CRFR signaling was assessed with intracerebroventricular (i.c.v.) infusion of the nonselective CRFR antagonist, alpha-helical CRF(9-41) (0, 1, 5, 10 microg/1 microl). The contribution of central CRF type 2 receptor (CRF(2)R) signaling was assessed with i.c.v. infusion of the selective CRF(2)R agonist, urocortin (Ucn) 3 (0, 0.05, 0.1, or 0.5 microg/1 microl). The role of the hypothalamic-pituitary-adrenal (HPA) axis was assessed by pretreating mice with intraperitoneal (i.p.) injection of (1) the corticosterone synthesis inhibitor, metyrapone (0, 50, 100, 150 mg/kg) or (2) the glucocorticoid receptor antagonist, mifepristone (0, 25, 50 mg/kg), and (3) by using radioimmunoassay to determine whether binge-like ethanol intake influenced plasma corticosterone levels. Finally, we determined whether the ability of the CRF(1)R antagonist, CP-154,526 (CP; 0, 10, 15 mg/kg, i.p.), to blunt binge-like drinking required normal HPA axis signaling by comparing the effectiveness of CP in adrenalectomized (ADX) and normal mice. Results showed that i.c.v. infusion of a 1 microg dose of alpha-helical CRF(9-41) significantly attenuated binge-like ethanol consumption relative to vehicle treatment, and i.c.v. infusion of Ucn 3 dose-dependently blunted binge-like drinking. On the other hand, metyrapone nonselectively reduced both ethanol and sucrose consumption, mifepristone did not alter ethanol drinking, and binge-like drinking did not correlate with plasma corticosterone levels. Finally, i.p. injection of CP significantly attenuated binge-like ethanol intake in both ADX and normal mice. Together, these results suggest that binge-like ethanol intake in C57BL/6J mice is modulated by CRF(1)R and CRF(2)R signaling, such that blockade of CRF(1)R or activation of CRF(2)R effectively reduces excessive ethanol intake. Furthermore, normal HPA axis signaling is not necessary to achieve binge-like drinking behavior.
最近的证据表明,促肾上腺皮质素释放因子(CRF)受体(CRFR)信号参与调节 C57BL/6J 小鼠的 binge-like 乙醇消耗。在本报告中,进行了一系列实验以进一步表征 CRFR 信号在 binge-like 乙醇消耗中的作用。通过脑室(i.c.v.)输注非选择性 CRFR 拮抗剂 α-螺旋 CRF(9-41)(0、1、5、10μg/1μl)来评估中枢 CRFR 信号的作用。通过脑室输注选择性 CRF2 受体(CRF2R)激动剂 Urocortin 3(0、0.05、0.1 或 0.5μg/1μl)来评估中枢 CRF 型 2 受体(CRF2R)信号的贡献。通过腹膜内(i.p.)注射(1)皮质酮合成抑制剂甲吡酮(0、50、100、150mg/kg)或(2)糖皮质激素受体拮抗剂米非司酮(0、25、50mg/kg)预处理小鼠来评估下丘脑-垂体-肾上腺(HPA)轴的作用,并用放射免疫测定法确定 binge-like 乙醇摄入是否影响血浆皮质酮水平。最后,我们确定了 CRF1R 拮抗剂 CP-154,526(CP;0、10、15mg/kg,i.p.)削弱 binge-like 饮酒的能力是否需要正常的 HPA 轴信号,方法是比较 CP 在肾上腺切除术(ADX)和正常小鼠中的有效性。结果表明,脑室输注 1μg 剂量的 α-螺旋 CRF(9-41)可显著减轻与载体处理相比的 binge-like 乙醇消耗,脑室输注 Ucn 3 剂量依赖性地减弱 binge-like 饮酒。另一方面,甲吡酮非选择性地降低乙醇和蔗糖的消耗,米非司酮不改变乙醇的摄入,并且 binge-like 饮酒与血浆皮质酮水平无关。最后,腹腔注射 CP 显著减轻 ADX 和正常小鼠的 binge-like 乙醇摄入。总之,这些结果表明,C57BL/6J 小鼠的 binge-like 乙醇摄入受 CRF1R 和 CRF2R 信号的调节,因此阻断 CRF1R 或激活 CRF2R 可有效减少过量的乙醇摄入。此外,正常的 HPA 轴信号对于实现 binge-like 饮酒行为不是必需的。